Wednesday, June 17, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 941 of 1,261
  1. US 8080578

    Methods for treatment with bucindolol based on genetic targeting

    The Regents of the University of Colorado, a Body Corporate · Granted Dec 20, 2011 · Expires Dec 15, 2031

    granted
  2. US 8080584

    Delayed release rasagiline citrate formulation

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Dec 20, 2011 · Expires Dec 15, 2031

    granted
  3. US 8080246

    Colony stimulating factor 1 receptor (CSF1R) extracellular domain fusion molecules

    Five Prime Therapeutics, Inc. · Granted Dec 20, 2011 · Expires Dec 15, 2031

    granted
  4. US 8080236

    Particulate materials

    Nektar Therapeutics UK, Ltd · Granted Dec 20, 2011 · Expires Dec 15, 2031

    granted
  5. US 8080241

    Viruses for the treatment of cellular proliferative disorders

    ONCOLYTICS BIOTECH INC. · Granted Dec 20, 2011 · Expires Dec 15, 2031

    granted
  6. US 8080248

    Method of treating rheumatoid arthritis with an IL-6R antibody

    REGENERON PHARMACEUTICALS, INC. · Granted Dec 20, 2011 · Expires Dec 15, 2031

    granted
  7. US 8080416

    Method for determining the immunogenicity of an antigen

    SANOFI PASTEUR VAXDESIGN CORPORATION · Granted Dec 20, 2011 · Expires Dec 15, 2031

    granted
  8. US 8080256

    Endophytic fungi from Pteromischum sp. plant, compounds and methods of use

    The Regents of the University of California · Granted Dec 20, 2011 · Expires Dec 15, 2031

    granted
  9. US 8080262

    Encapsulated peptide amphiphile nanostructures

    Northwestern University · Granted Dec 20, 2011 · Expires Dec 15, 2031

    granted
  10. US 8080527

    Methods and compositions for prevention and treatment of inflammatory disease, autoimmune disease, and transplant rejection

    The Regents of the University of California · Granted Dec 20, 2011 · Expires Dec 15, 2031

    granted
  11. US 8080554

    Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Dec 20, 2011 · Expires Dec 15, 2031

    granted
  12. US 8080532

    Compositions and methods for inhibiting expression of Huntingtin gene

    Alnylam Pharmaceuticals, Inc. · Granted Dec 20, 2011 · Expires Dec 15, 2031

    granted
  13. US 8080565

    Substituted 4-amino-benzylpiperidine compounds

    Theravance, Inc. · Granted Dec 20, 2011 · Expires Dec 15, 2031

    granted
  14. US 8076357

    Compositions of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

    Vertex Pharmaceuticals Incorporated · Granted Dec 13, 2011 · Expires Dec 8, 2031

    granted
  15. US 8076353

    Inhibition of VEGF translation

    PTC THERAPEUTICS, INC. · Granted Dec 13, 2011 · Expires Dec 8, 2031

    granted
  16. US 8076412

    Water-soluble polymer alkanals

    Nektar Therapeutics · Granted Dec 13, 2011 · Expires Dec 8, 2031

    granted
  17. US 8076372

    Acythiols and component thiol compositions as anti-HIV and anti-retroviral agents

    The Government of the United States · Granted Dec 13, 2011 · Expires Dec 8, 2031

    granted
  18. US 8076343

    Benzimidazoles useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Dec 13, 2011 · Expires Dec 8, 2031

    granted
  19. US 8076352

    Administration of carboline derivatives useful in the treatment of cancer and other diseases

    PTC THERAPEUTICS, INC. · Granted Dec 13, 2011 · Expires Dec 8, 2031

    granted
  20. US 8076451

    Selective delivery of molecules into cells or marking of cells in diseased tissue regions using environmentally sensitive transmembrane peptide

    Board of Governors for Higher Education, State of Rhode Island and Providence Plantations · Granted Dec 13, 2011 · Expires Dec 8, 2031

    granted
  21. US 8076470

    VMP-like sequences of pathogenic Borrelia species and strains

    The Board of Regents of the University of Texas System · Granted Dec 13, 2011 · Expires Dec 8, 2031

    granted
  22. US 8076294

    Collagen-related peptides and uses thereof

    Advanced Technologies and Regenerative Medicine, LLC · Granted Dec 13, 2011 · Expires Dec 8, 2031

    granted
  23. US 8076099

    Biomarkers of Francisella infection

    The Board of Regents of the University of Texas System · Granted Dec 13, 2011 · Expires Dec 8, 2031

    granted
  24. US 8075904

    High aspect ratio template and method for producing same for central and peripheral nerve repair

    The Regents of the University of California · Granted Dec 13, 2011 · Expires Dec 8, 2031

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.